Dicks Sporting Goods Inc vs McKesson Corporation — how do they compare? Dicks Sporting Goods Inc trades at $206.29 (market cap $18.35B), while McKesson Corporation trades at $895 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 5.7× Dicks Sporting Goods Inc's market cap, and Dicks Sporting Goods Inc pays the higher dividend (2.44%). Which is the better fit depends on your goals.
| DKS | MCK | |
|---|---|---|
Market Cap | $18.35B | $105.14B |
Sector | Consumer Cyclical | Health |
52-Week High | $239.17 | $995.69 |
52-Week Low | $187.78 | $659.01 |
Enterprise Value | $25.14B | $111.67B |
Dividend Yield | 2.44% | 0.42% |
Signals from Pluang's Aura AI — not financial advice
DICK'S Sporting Goods (DKS) trades at $208.84, up 5.15% with strong earnings momentum after beating estimates for three consecutive quarters. The stock shows neutral technical signals with support at $201 and resistance at $213. Fundamentally, the company maintains solid profitability with 20.9% ROE and 4.71% net margin, though cash flow trends show modest net outflows. Recent news highlights analyst upgrades and the upcoming Q2 earnings call on August 25th.
The investment outlook remains positive with 59% analyst buy ratings and a $263.22 consensus target representing 26% upside. Key risks include potential fiduciary duty investigations and competitive pressures in sporting goods retail. The company's consistent earnings beats and expanding women's sports investments provide catalysts, though investors should monitor cash flow sustainability and market volatility.
No Aura AI signal available yet.
Trailing returns across standard periods
Dick's Sporting Goods is a leading omni-channel sporting goods retailer in the US It offers an extensive assortment of authentic sports equipment, apparel, footwear, and accessories through its stores and digital platforms.
Read more on DKS →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →